Consistent with reduced tumor load, Gal-1 expression, low in healthy livers, was markedly elevated in HCC but significantly reduced in response to miR-22 treatment, as shown by Western blot and immunohistochemical (IHC) (Fig. 3C-D). The gene discussed is LGALS1; the disease is neoplasm.